UBS Group AG BLTE BELITE BIO INC

Ownership history in UBS Group AG  ·  13 quarters on record

AI Ownership Summary

UBS Group AG reported BELITE BIO INC (BLTE) in 13 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 0.02% in 2026 Q1. The latest visible filing shows BLTE at 0.02% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this BLTE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was UBS Group AG's position in BELITE BIO INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

BLTE was reported at 0.02% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.02% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How UBS Group AG held BLTE — position size vs. price
% of Fund (quarterly)    BLTE price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED 768,359 +639,607 +496.8% 0.02% $122.5M 2026-05-05 $154.38
2025 Q4 ADDED 128,752 +117,418 +1036.0% 0.00% $20.6M 2026-01-29 $169.02
2025 Q3 ADDED 11,334 +8,976 +380.7% 0.00% $839K 2025-11-13 $112.41
2025 Q2 ADDED 2,358 +1,807 +327.9% 0.00% $136K 2025-08-14 $68.98
2025 Q1 REDUCED 95.5% -12.9% 551 -11,656 -95.5% 0.00% $36K 2025-05-13 $60.89
2024 Q4 ADDED 12,207 +12,079 +9436.7% 0.00% $770K 2025-02-14 $56.00
2024 Q3 REDUCED 63.2% +32.2% 128 -220 -63.2% 0.00% $6K 2024-11-14 $83.66
2023 Q4 REDUCED 60.6% -19.3% 348 -535 -60.6% 0.00% $16K 2024-02-09 $47.55
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About UBS Group AG and BLTE

These are the practical questions this page is built to answer before you even open the full history table.

How long has UBS Group AG reported owning BLTE?

UBS Group AG reported BLTE across 8 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported BLTE position in UBS Group AG's portfolio?

The largest reported portfolio weight for BLTE was 0.02% in 2026 Q1.

What is the latest reported BLTE position on this page?

The most recent filing on this page is 2026 Q1, when UBS Group AG reported 768,359 shares, equal to 0.02% of portfolio, with an estimated market value of $122.5M.

What does the chart on this BLTE ownership page compare?

The chart compares UBS Group AG's quarterly BLTE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did UBS Group AG time their BLTE position?

Based on 13F filing dates vs. subsequent BLTE price moves, UBS Group AG correctly timed 8 out of 12 reported position changes (67%).

← Back to UBS Group AG Holdings